You are here
AdvaMed Statement on House Passage of Tax Legislation
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker following the passage of H.R. 88, as amended, by the U.S. House of Representatives:
“The medical device tax stifles innovation, jeopardizes job creation and economic growth, and, ultimately, hurts health progress. A five-year moratorium on the medical device tax, as is included in the just-passed House tax package, will help address these threats and ensure patients can continue to access cutting-edge medtech treatments and cures.
“We appreciate the House’s current effort to curtail the medical device tax—and we appreciate their passage of full repeal of the device tax earlier this year. We especially thank Ways and Means Chairman Kevin Brady, Rep. Erik Paulsen, and Rep. Jackie Walorski, as well as House Republican leadership, for their commitment to this cause. We urge the Senate to act on the positive momentum the House has set and pass this bill to extend the moratorium to incentivize job growth and continued health care advancement.”
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.